$AZN

$155.80▲ -0.7% YTD

4 SEC 13D/G filings tracked · Last updated Oct 5, 2026

Filing History

AZN ▼ -0.7% - AstraZeneca PLC

CP $155.80▲ -0.7%Oct 5, 2026 · ThinkSabio Blog

$AZN INVESTS $1 BLN TO GROW MASSACHUSETTS WORKFORCE BY OVER 50%…

AZN ▼ -1.3% - AstraZeneca PLC

CP $162.48▲ -1.3%Sep 4, 2026 · ThinkSabio Blog

$AZN - Talk FDA Grants Accelerated Approval to a New Breast Cancer Treatment (SM Circulations)…

AZN ▼ -0.8% - AstraZeneca PLC

CP $160.99▲ -0.8%Sep 1, 2026 · ThinkSabio Blog

$AZN AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer…

AZN ▼ -0.6% - AstraZeneca PLC

CP 165.22▲ -0.6%Aug 27, 2026 · ThinkSabio Blog

$AZN TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints…